Kaposi's sarcoma: Pathogenesis and basic therapy


Cite item

Full Text

Abstract

Two female patients with Kaposi’s sarcoma (KS) are described. In one KS manifested by typical and bullous efflorescence. Bullous KS developed as a result of secondary immunosuppression, caused by a long course of systemic glucocorticoid hormone (metiprede) and immunosuppressant endoxane for systemic scleroderma.

About the authors

N. S Potekaev

I.M.Setchenov First Moscow State Medical University

член-корреспондент РАМН, доктор мед. наук, профессор

G. A Panshin

Russian Center of X-Ray Diagnosis

доктор мед. наук, профессор

N. P Teplyuk

I.M.Setchenov First Moscow State Medical University

доктор мед. наук, профессор

N. S Arsentyev

I.M.Setchenov First Moscow State Medical University

врач

E. Yu Vertieva

I.M.Setchenov First Moscow State Medical University

Email: ivertieva@gmail.com
врач, кандидат мед. наук

G. I Makhov

I.M.Setchenov First Moscow State Medical University

врач

E. S Sizova

I.M.Setchenov First Moscow State Medical University

студентка

V. S Paukov

M.F. Vladimirsky Moscow Regional Research and Clinical Institute

акад. РАМН, доктор мед. наук, профессор

M. G Kartashova

I.M.Setchenov First Moscow State Medical University

кандидат мед. наук, научный сотрудник

References

  1. Молочков В.А., Молочков А.В. Клиническая дерматоонкология. М.: МДВ; 2011.
  2. Di Lorenzo G. Update on classic Kaposi sarcoma therapy: new look at an old disease. Crit. Rev. Oncol. Hematol. 2008; 68(3): 242-9.
  3. Dal Maso L., Polesel J., Ascoli V., Zambon P., Burdoni M., Feretti S., et al. Classic Kaposi’s sarcoma in Italy. Br. J. Cancer. 2005; 92(1): 188-93.
  4. Chang Y., Cesarman E., Pessin M., Lee F., Culpepper J., Knowles D.M., et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science. 1994; 266 (5192): 1865-9.
  5. Rezaee Rahim S.A., Cunningham C., Davison A.J., Blackbourn D.J. Kaposi’s sarcoma-associated herpesvirus immune modulation: an overview. J. General Virol. 2006; 87(7): 1781-804.
  6. Sullivan R., Dezube B.J., Koon H.B. Signal transduction targets in Kaposi’s sarcoma. Curr. Opin. Oncol. 2006; 18(5): 456-62.
  7. Sullivan R.J., Pantanowitz L., Casper C., Stebbing J., Dezube B.J. Epidemiology, pathophysiology and treatment of Kaposi’s sarcoma-associated herpesvirus disease: Kaposi Sarcoma, primary effusion lymphoma and Multicentric Castleman disease. Clin. Infect. Dis. 2008; 47(9): 1209-15.
  8. Knowles D.M., Cesarman E. The Kaposi’s sarcoma-associated herpesvirus (human herpesvirus-8) in Kaposi’s sarcoma, malignant lymphoma, and other diseases. Ann. Oncol. 1997; 8(2): 123-9.
  9. Jin Y.T., Tsai S.T., Yan J.J. Detection of Kaposi’s sarcoma-associated herpesvirus-like DNA sequence in vascular lesions: a reliable diagnostic marker for Kaposi’s sarcoma. J. Clin. Pathol. 1996; 105(3): 360-3.
  10. Alkharsah K.R., Dedicoat M., Blasczyk R., Newton R., Schulz T.F. Influence of HLA alleles on shedding of Kaposi sarcoma-associated herpesvirus in saliva in an African population. J. Infect. Dis. 2007; 195(6): 809-16.
  11. Guerini F. R., Agliardi C., Mansuco R., Brambilla L., Biffi R.,Ferrucci S.,Zanetta L. Association of HLA-DRB1 and HLA-DQB1 with Classic Kaposi’s Sarcoma in Mainland Italy. Cancer Genom. Proteomics. 2006; 3: 191-6.
  12. Guerini R., Mancuso R., Agostini S., Agliardi C., Zanzottera M., Hernis A., et al. Activating KIR/HLA complexes in classic Kaposi’s Sarcoma. Infectious Agents and Cancer. 2012; 7 (1):7-9.
  13. Потекаев Н.С. Дерматовенерология - синтез науки и практики. Избранные труды. М.: Медицинская книга, 2004: 341-2.
  14. Скрипкин Ю.К. Кожные и венерические болезни: Руководство для врачей. Скрипкин Ю.К., ред. М.: Медицина 1999; т.2: 554-68.
  15. Каламкарян А.А., Мордовцев В.Н., Трофимова Л.Я. Клиническая дерматология: Редкие и атипичные дерматозы. Ереван; 1989: 465-6.
  16. Volkow P., Zinser J.W., Correa-Rotter R. Molecularly targeted therapy for Kaposi’s sarcoma in a kidney transplant patient: case report, "what worked and what did not". BMC Nephrol. 2007; 27(8): 6.
  17. Stallone G., Schena A., Infante B., Di Paolo S., Loverre A. Sirolimus for Kaposi’s Sarcoma in Renal-Transplant Recipients. N. Engl. J. Med. 2005; 352 (13): 1317-23.

Copyright (c) 2013 Eco-Vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies